We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Novel Stem Cell Therapy Eliminates Brain Tumors in Mouse Model

By LabMedica International staff writers
Posted on 04 May 2015
Print article
Image: Tagged therapeutic stem cells (green) are targeting breast cancer metastases (red) in the brain of a mouse model (Photo courtesy of Dr. Khalid Shah, Massachusetts General Hospital).
Image: Tagged therapeutic stem cells (green) are targeting breast cancer metastases (red) in the brain of a mouse model (Photo courtesy of Dr. Khalid Shah, Massachusetts General Hospital).
Cancer researchers have developed a novel stem cell therapeutic approach for treating breast cancer that has spread to the brain.

Investigators at Massachusetts General Hospital (Boston, USA) and the Harvard Stem Cell Institute (Boston, MA, USA) initially developed an in vivo imageable breast-to-brain metastasis mouse model. Using real time in vivo imaging and subsequent composite fluorescence imaging, they demonstrated in the brains of the mice widespread distribution of micro- and macro-metastasis in different stages of metastatic progression. They also showed extravasation of tumor cells and the close association of tumor cells with blood vessels in the brain thus mimicking the multi-foci metastases observed in human patients.

To treat the breast tumors that had developed in the brains of the mice the investigators created a line of genetically engineered adult stem cells. The stem cells, which were known to be naturally attracted toward tumors in the brain, were modified in two ways. The genomes of the stem cells were altered by insertion of two genes, the gene for a variant of TRAIL (TNF receptor superfamily member 10A/10B apoptosis-inducing ligand) and the gene for herpes simplex virus thymidine kinase (HSV-TK).

TRAIL is a cytokine that is produced and secreted by most normal tissue cells. It causes apoptosis primarily in tumor cells by binding to certain death receptors. Since the mid-1990s it has been used as the basis for several anti-cancer drugs. The presence of the HSV-TK gene rendered the stem cells susceptible to the effects of the antiviral drug ganciclovir.

In experiments described in the April 24, 2015, online edition of the journal Brain, the investigators injected the modified stem cells into the brains of the mice. Imaging confirmed that the stem cells traveled to multiple metastatic sites and not to tumor-free areas. TRAIL secreted by the stem cells reduced growth of the tumors. Following inhibition of tumor growth, the stem cells were destroyed by injecting the mice with ganciclovir.

"Metastatic brain tumors - often from lung, breast or skin cancers - are the most commonly observed tumors within the brain and account for about 30% of advanced breast cancer metastases," said senior author Dr. Khalid Shah, professor of radiology and neurology at Massachusetts General Hospital. "Our results are the first to provide insight into ways of targeting brain metastases with stem-cell-directed molecules that specifically induce the death of tumor cells and then eliminating the therapeutic stem cells."

Related Links:

Massachusetts General Hospital
Harvard Stem Cell Institute


New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: The FDA clearance for the QIAstat-Dx Respiratory Panel Mini test follows the recent approval of QIAstat-Dx Respiratory Panel Plus (Photo courtesy of QIAGEN)

Respiratory Panel to Help Clinicians Make Precise Treatment Decisions in Outpatient Settings

Respiratory tract infections are the primary reason for visits to emergency departments and subsequent hospitalizations. In the U.S., it is estimated that there are up to 41 million cases of influenza... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more